Next Generation Partners

Healthcare and life sciences in Sweden

Cirio Advokatbyrå AB

Cirio Advokatbyrå AB houses a team which is noted for its ‘large and in-depth‘ knowledge of the life sciences sector. The group handles a wide variety of mandates involving market access, rights issuances of shares, and trade mark mandates concerning parallel imports. Practice head Per Hedman utilises his vast regulatory knowledge to advise international pharma, medtech and biotech companies and investment entities. Praised for her specialism in personal data protection which makes her ‘unique within the Swedish market‘, Hanna Tilus is known for advising on technology transfers, co-marketing issues, and R&D collaborations.

Responsables de la pratique:

Per Hedman


Autres avocats clés:

Odd Swarting; Hanna Tilus


Les références

‘This team blends strong, commercial legal work with a deep industry knowledge in life sciences. They are hard to match in this combination. The team is also very responsive on legal queries outside major engagements, meaning they act as a trusted and reliable adviser.’

‘Per Hedman is our most trusted legal adviser in Sweden. He gives actionable, practical advice without unnecessary complexity. He blends this with deep life sciences expertise, making him a seamless lawyer to work with. He is responsive and always available in a crisis!’

‘The Cirio team are solutions-oriented and deliver clear advice that is easy to implement in our internal routines and procedures.’

Principaux clients

Takeda


10x Genomics


Ipsen


Recipharm


Boule Diagnostics


Hadean Ventures


Karolinska Development


Intervacc


Scandinavian Biopharma


Sprint Bioscience


Abliva


Symcel


Annexin Pharmaceutcials


AlzeCure Pharma


Nordberg Medical


Lamera Medical


FrostPharma


Sprint Bioscience AB


Principaux dossiers


  • Represented Takeda in a market access matter.
  • Advised Ipsen on its acquisition of Albireo Pharma Inc (including two Swedish subsidiaries).
  • Advised Boule Diagnostics AB on its rights issuance of shares through which the company raised approximately SEK150m.

Mannheimer Swartling

Mannheimer Swartling houses a ‘highly skilled‘ practice, which acts for a diverse client base of medical device manufacturers, domestic and global pharma companies, and innovation focused healthcare providers. The ‘superbCamilla Appelgren leads the team, and is well known for advising on a range of regulatory matters, including cases against national agencies concerning pricing and reimbursement, market access, and clinical trials. ‘Very wise adviserPeter Nilsson Torres has notable knowledge surrounding trial subject data issues and research projects, having assisted numerous healthcare and pharma clients. Emmie Montgomery is particularly adept at advising clients on the processing of patient data, in addition to advertisement-related issues.

Responsables de la pratique:

Camilla Appelgren


Autres avocats clés:

Peter Nilsson; Emmie Montgomery


Les références

‘Camilla Appelgren possesses a deep understanding of her field, demonstrating quick thinking and offering well-balanced advice. We value her professionalism and personal touch.’

‘Top tier team with an extensive knowledge within the life science area.’

‘Mannheimer Swartling always puts together a tight team, ensuring the right expertise for the topic at hand. They have deep experience within Pharma/Life Sciences with broad competences. It has always been easy to work with Mannheimer on challenging and complex issues – and the team has offered expert advice in a timely fashion.’

Principaux clients

Bristol-Myers Squibb


Celgene


Swedish Orphan Biovitrum AB


AbbVie AB


Inceptua S.A.


Lipum AB


Capio AB


Capio S:t Görans Sjukhus AB


Camurus AB


Janssen-Cilag


Amgen


Humana Assistans AB


Principaux dossiers


  • Represented Humana Assistans AB in major administrative court proceedings to challenge and set aside a decision by the Swedish Health and Social Care Inspectorate to revoke Humana’s operating permit.
  • Assisting BMS and Celgene (a BMS group company) with regulatory, commercial, pricing and reimbursement, and compliance matters.
  • Advised Impilo on its acquisition of Decon Wheel AB and VaccinDirekt.

Setterwalls

Rated by clients as being ‘in a league of its own‘, Setterwalls maintains its stellar reputation for handling the full spectrum of mandates for diagnostic companies, drug distributors, and medical device clients. The group exhibits broad expertise in M&A, licensing and supply agreements, and disputes concerning generics and biosimilars. Leading the practice out of the Malmö office, Per Lidman is known for his longstanding IP expertise, regularly acting for pharma and medtech clients in patent disputes. Martin Levinsohn maintains an IP and competition-focused practice, with his caseload including market exclusivity and marketing-related issues within life sciences. Regulatory specialist Helena Nilsson is well-versed in mandates involving clinical studies, and classification and distribution issues.

Responsables de la pratique:

Per Lidman


Autres avocats clés:

Helena Nilsson; Martin Levinsohn; Hanna Sonning; Lovisa Dahl Nelson; Richard Hammarvid


Les références

‘They have a broad team with knowledge about the pharmaceutical market in Sweden.’

‘Martin Levihnson has deep knowledge and understanding of the pharma sector in Sweden. He is analytical and very skilled in presenting a case.’

‘Setterwalls has the unique ability to provide a team where all individuals have special but still overlapping competences. Their internal cooperation is immaculate and everyone had very high work ethics and competence. Setterwalls are not comparable with the other firms, but are in a league of their own.’

Principaux clients

Abacus Medicine


Accord Healthcare


Apoteksgruppen i Borrby nr 1 AB


Barry Callebaut


Blodtrycksdoktorn


Cloetta


Coala Life


Doktorse Nordic


EQL Pharma


Fresenius Kabi


Gnosco AB


Gutfeeling Labs


Index Pharmaceuticals


Isofol Medical AB


Move & Walk Sverige AB


Mylan/Viatris


Neuraxpharm


Nordic Trading Group


Novo Nordisk


Orifarm


Respiratorius


Sandoz


Sever Pharma Solutions


Zentiva


Principaux dossiers


  • Representing Nordic Trading Group B.V. against the Medical Products Agency (MPA) in the Supreme Administrative Court against the MPA’s decision to prohibit online sales of cannabidiol products to consumers in Sweden.
  • Representing Sandoz in a patent dispute with Bayer concerning Bayer’s patent for a once-daily dosing regimen for the active ingredient rivaroxaban, which is a pharmaceutical used in the prevention and treatment of thromboembolism.
  • Representing Neuraxpharm, a Spanish supplier of generic medicines, in a patent dispute against Biogen concerning Biogen’s patent for a specific dose of the active ingredient dimethylfumarate, which is used in the treatment of MS.

Advokatfirman Vinge

Advokatfirman Vinge houses a ‘highly skilled‘ team which is well-known for its expertise in patent disputes concerning royalty agreements, patent assignments, and supplementary protection certificates (SPC). The group frequently assists global pharma and biotech companies, healthcare corporates and investment funds within the life sciences and consumer health sectors. The ‘exceptionalStojan Arnerstål leads the team, and maintains a transaction-focused practice, advising on a range of manufacturing, commercialisation and development agreements within the pharma space. Noted for the ‘unrivalled depth‘ of his knowledge, Håkan Borgenhäll is an IP specialist who has notable experience in handling contentious matters involving registered designs, marketing issues and trade marks.

Responsables de la pratique:

Stojan Arnerstål


Autres avocats clés:

Håkan Borgenhäll; Malin Malm Waerme; Lisa Hörnqvist


Les références

‘Stojan Arnerstål is an exceptional adviser for commercial agreements, providing real value through his pragmatic, business-oriented approach and quick turnarounds in our matters. Excellent management skills.’

‘Vinge’s practice provides broad coverage and in-depth knowledge of the sector. They have a solid group of lawyers who are very responsive with a commercial mindset.’

‘Stojan Arnerstål has excellent knowledge and experience of the healthcare and life sciences industry. He is very skilled in conveying legal advice on commercial and complex matters in a practical and engaging way across all areas of the industry.’

Principaux clients

Eli Lilly and Company


Bridgepoint Growth


Fidelio Capital


Recipharm AB


Atlas Antibodies AB


Tamro AB


Vimian Group AB


Corline Biomedical AB


Medivir AB


Xspray Pharma AB


Hansa Biopharma AB


Calliditas Therapeutics AB


Oncopeptides AB


BioGaia AB


Nanoform Finland Plc


Medicover AB


Järven Plast & Smide Aktiebolag


Cinclus Pharma


A3P Biomedical


Healthcap


Attgeno AB


Principaux dossiers


  • Representing Latvia MGI Tech SIA, MGI Tech Hong Kong Co., Ltd. and MGI International Sales Co., Ltd in 12 patent disputes where the counterpart is Illumina, a US company.
  • Represented Hansa Biopharma in an arbitration related to a patent assignment and royalty agreement and the request for royalties from certain researchers. The matter included complex interpretation of patent assignment and licensing agreements, including interpretation of the scope of protection of multiple patents.
  • Represented Attgeno in connection with an appeal to the Swedish Information Practices Committee (NBL). The matter concerned whether a paid article published by the company in collaboration with a newspaper was to be considered permitted scientific information regarding a certain medical condition, or whether the article was to be considered as unlawful pre-launch advertising of a not-yet approved pharmaceutical.

Advokatfirman Delphi

The ‘experienced and skilled‘ team at Advokatfirman Delphi acts for numerous pharma, medtech, and healthcare companies with a strong focus on innovation. Primarily based in Stockholm, the group has experienced growth in its workload with regard to regulatory advice on medical devices, and healthcare compliance. Practice head Elisabeth Eklund maintains a life sciences regulatory and competition-focused practice, with her primary area of focus being pricing and reimbursement cases, and distribution issues. Malmö’s Micael Karlsson regularly assists clients with corporate social responsibility issues, IPOs, and licensing matters. Public procurement specialist Martin Bogg regularly advises on the interpretation of government contracts, and the execution of public procurements.

Responsables de la pratique:

Elisabeth Eklund


Autres avocats clés:

Martin Bogg; Agne Lindberg; Peter Nordberg; Micael Karlsson


Les références

‘Team representing the key areas of interest within the field.’

‘The team has an exceptional understanding of the specific business needs in the life sciences sector.’

‘High level of engagement and with strong customer focus. Deliver on time, very speedy and with very high quality. The experienced and skilled personnel give the customer a high level of confidence.’

Principaux clients

Inera AB


Intuitive Surgical Sarl


Nordicinfu Care AB


Unilabs AB


Hamlet Pharma AB


Olink Holding AB


Mendus AB


MTIP Fund II, SCSp


Enorama Pharma AB


Medimi AB


ProstaLund AB


Simris Group AB


Pharmacosmos AB


Principaux dossiers


  • Assisted Inera AB with IT-procurements with a maximum value of more than SEK2.7 bn, concerning Sweden’s main healthcare applications, such as 1177.se, a website which provides information about illnesses, care and health from the regions providing healthcare in Sweden.
  • Advised Olink Holding AB on the $116m offering of American Depositary Shares (ADSs). Each ADS represents one share in the company and the ADSs in the offering consisted of both newly issued shares and existing shares sold by certain shareholders of the company.

Advokatfirman Cederquist KB

The group at Advokatfirman Cederquist KB handles the full spectrum of matters concerning ethical codes and contracts with regulatory authorities within the life sciences and healthcare sector. Malin Allard and Annika Blomqvist jointly head up the practice. Allard is known for her longstanding IP expertise, with technology licensing agreements, strategic IP rights protection, and infringement actions being her main areas of focus. Blomqvist leads the public procurement practice at the firm, advising on distribution agreements, collaboration agreements with healthcare professionals, and clinical study commercial contracts. Dispute resolution expert Elsa Arbrandt acts in international arbitrations and regulatory disputes concerning clinical trials, in addition to advising on internal investigations.

Responsables de la pratique:

Malin Allard; Annika Blomqvist


Autres avocats clés:

Elsa Arbrandt


Les références

‘A very high level of service mindedness. A genuine interest in our needs and our success.’

Principaux clients

S Ahlén Medical Nordic AB


Aktiv Ortopedteknik i Sverige AB


Orkla ASA


Principaux dossiers


  • Representing If Skadeförsäkring AB in complex court proceedings before the Stockholm District Court regarding serial loss claims involving several insurance companies, emanating from a number of ongoing class actions in North America and Canada.
  • Advised Lithuanian pharmacy company Euroapotheca on its joint combination with the Finnish company Oriola.
  • Advising a client on its negotiations for a distribution agreement with a manufacturer.

Westerberg & Partners

Westerberg & Partners‘ practice frequently assists pharma clients with product launches within the Swedish market. In addition to the group’s extensive contentious IP capability, it also regularly advises on research and development agreements. ‘Excellent‘ patent litigator Jonas Löfgren leads the team with his deep regulatory expertise, with particular emphasis on market access, and pricing and reimbursement matters. Wendela Hårdemark is well-versed in contentious matters concerning license agreements. Ludvig Holm regularly acts in patent and trade mark disputes, while Jonas Westerberg is noted for his vast knowledge of IP litigation and arbitration.

Responsables de la pratique:

Jonas Löfgren


Autres avocats clés:

Wendela Hårdemark; Ludvig Holm; Jonas Westerberg; Siri Alvsing


Les références

‘Jonas Löfgren is very experienced, with great knowledge of the Swedish market. He is very responsive and provides constant great legal support and practical solutions.’

‘First rate service. Jonas Löfgren in particular is excellent.’

‘Jonas Löfgren has hard-edged experience and is practical on very technical issues.’

Principaux clients

Alnylam Pharmaceuticals


GlaxoSmithKline


Novartis


Dr Wolff Group


Karo Healthcare


Illumina, Inc


Principaux dossiers


  • Acted for Illumina in a multitude of parallel patent proceedings regarding the infringement and validity of patents in the DNA sequencing field.
  • Advised Dr. Wolf Group on the market access in Sweden of its first medicinal product, Axhidrox.

Hammarskiöld

The ‘outstandingMalin von Heideken leads the team at Hammarskiöld, which handles a vast range of issues for its varied client base of generics manufacturers, parallel traders and pharma companies. The practice is well versed in non-contentious matters, including the drafting and negotiation of license and R&D agreements. Von Heideken is noted for her broad experience in representing clients before the Swedish administrative courts in commercial cases against government agencies. Sofia Falkner has a great deal of regulatory expertise, with her primary areas of focus being the pharma and medtech sectors. Falkner also has deep knowledge of Swedish and EU competition law, advising on a number of cartel investigations and the management of internal investigations.

Responsables de la pratique:

Malin von Heideken


Autres avocats clés:

Sofia Falkner


Les références

‘Highly professional, flexible and able to work on a risk-based basis. Not wasting resources while providing excellent advice.’

‘Very knowledgeable within life sciences and related legal matters, high availability and short turnaround times.’

‘Malin von Heideken is an outstanding partner to work with. Very professional in all aspects and high level of availability.’

Principaux clients

Cellcolabs


Sirona


Asker Group (OneMed)


Devyser


Sigrid


Psomri


Orifarm


EpiEndo Pharmaceuticals


Norgine


Althea Group


Thermo Fisher Scientific


Tieto


Principaux dossiers


  • Advised Sigrid on its clinical programme on SiPore, including legal aspects in relation to clinical studies. Also negotiated clinical study agreements, clinical research organisation agreements, and related services agreements.
  • Acted for Orifarm in two Administrative Court cases against the Swedish Medical Products Agency. The team is currently advising Orifarm in relation to one of these cases, which has been appealed to the Supreme Administrative Court.
  • Advised Cellcolabs on regulatory issues in relation to marketing and clinical trials. The team has also advised Cellcolabs on the negotiation of a major license agreement.

Advokatfirman Lindahl KB

Advokatfirman Lindahl KB houses a group known for its ‘strong and deep‘ knowledge of the sector, regularly assisting start-ups and venture capital backed companies, in addition to international players in the pharma industry. Praised for his ‘excellent‘ industry knowledge, Hugo Norlén leads the Uppsala-based team with his longstanding expertise in strategic collaborations and technology transfers within the pharma, medtech and biotech spaces. Gunnar Mattsson is noted for his broad expertise in corporate and international contractual matters, acting for a number of public and private life sciences companies, while Mikael Smedeby regularly handles issues concerning M&A and licensing transactions.

Responsables de la pratique:

Hugo Norlén


Autres avocats clés:

Gunnar Mattsson; Mikael Smedeby


Les références

‘Really client centered – always there when you need them, and rallies to bring the best team together depending on the area of expertise needed in each case. Strong and deep knowledge in the field of life sciences, makes a difference to work with an industry expert compared to a generalist.’

‘Down to earth, committed to the client, fast, problem-solving approach. Hugo Norlén has excellent industry knowledge and is really service-minded. He’s also really good at bringing in other parts of the team, when other expertise is needed.’

‘Good background knowledge and understanding of our business model, and the dynamics of the pharma industry in general. Pragmatic approach with valuable sharing of creative ideas to overcome roadblocks in negotiations. Very committed team, responsive and available when needed.’

Principaux clients

Affibody AB


Philips AB, Personal Heath


BioArctic AB


Palette Life Sciences AB


ThermoFisher Scientific/Phadia AB


Q-linea AB


Orexo AB


Senzime AB


Egetis Therapeutics AB


Eurocine Vaccines AB


Nanologica AB


Ilya Pharma AB


Vitrolife AB


Redwood Pharma AB


AMRA Medical AB


Dilafor AB


Nanexa AB


Intrance Medical Systems Inc


NeoDynamics AB


Miris AB


Stardots AB


BioLamina AB


Navinci Diagnostics AB


Salipro Biotech AB


Principaux dossiers


  • Advised Palette Life Sciences on Teleflex’s $650m acquisition of the company.
  • Advised Corline Biomedical on a license agreement with the California-based company Imperative Care, with a total deal value of SEK1bn (approx. $90m).
  • Advised Ziccum in connection with a fully funded evaluation agreement with an international biopharmaceutical corporation focused on mRNA technologies.

Magnusson Advokatbyrå

Possessing ‘undeniable‘ expertise, the team at Magnusson Sweden is known for its expansive experience in public procurement work, with particular emphasis placed on patient safety and workflows, in addition to advising on commercial matters relating to the public sector. ‘Great‘ practice head Morvarid Dorkhan Nilsson regularly assists clients with a broad range of mandates, including the negotiation and drafting of manufacturing agreements, internal ethical guidelines, and permittable modifications to public procurement contracts. Helena Rönqvist maintains an IP and marketing focused practice, handling numerous commercial and IT agreements, while Wille Steinert is noted for his expertise in supply chains and the implementation of international policies and regulatory requirements.

Responsables de la pratique:

Morvarid Dorkhan Nilsson


Autres avocats clés:

Helena Rönqvist; Wille Steinert


Les références

‘They demonstrate the exceptional ability to be highly responsive to our specific needs on every occasion. One of their standout qualities is their capacity to rapidly comprehend and grasp the nuances of our situations and challenges. Every interaction feels as though we are their top priority, a sentiment that instills a strong sense of trust and partnership.’

‘Their expertise in our domain is undeniable, providing us with the confidence that our concerns are always framed within the correct legal context. Compared to other firms, their hands-on approach and tailored solutions truly set them apart.’

‘The individuals at the firm, much like the team as a whole, exemplify a dedication to understanding our specific needs. Among them, Morvarid Dorkhan Nilsson truly shines. She consistently nails the bullseye in grasping our requirements and delivering the right outcomes. Their level of personal commitment and expertise, especially from standout figures like Morvarid, is what sets them apart and adds immense value to our collaboration.’

Principaux clients

Becton Dickinson AB


Sedana Medical AB


Mediq Sverige AB


MediRum AB


Sverek AB


Continuum AB


Principaux dossiers


  • Advised a global medical technology company on the complete review, implementation and alignment of global guidelines, policies and standard operating procedures to all Swedish laws and ethical guidelines applicable to medtech and pharmaceutical companies, with particular focus on interactions between the industry and the healthcare sector.
  • Assisted a publicly listed client within the medtech and pharmaceuticals industries, with particular focus on inhaled sedation. The team assisted with drafting and negotiating the necessary contract manufacturing agreements to outsource manufacturing.
  • Advised an innovative client on patient support programs, with detailing, analysing and complying with the framework of laws, industry standards and ethical guidelines applicable when implementing a patient support program in Sweden and Denmark.

Roschier

Noted by clients for its ‘precision and skills‘, the team at Roschier is known for handling a variety of matters for its varied client base of innovation focused digital healthcare and pharma companies. Erik Ficks heads up the practice, and has broad experience in advising on transactional matters, including share acquisitions, in addition to acting in patent infringement actions in the pharma space. Björn Johansson Heigis leads the firm’s data protection and digitalisation practice, and is well versed in handling GDPR-related issues concerning medical devices, and research and development matters.

Responsables de la pratique:

Erik Ficks


Autres avocats clés:

Björn Johansson Heigis; Elias Olsson


Les références

‘The precision and skills from the team have helped us countless times and in particular Erik Ficks, with his skills, and ability to execute according to our agreed strategy, have been key to our strategy.’

Principaux clients

Neurim Pharmaceuticals


Philip Morris International


Principaux dossiers


  • Representing Philip Morris International in its SEK176.4bn public offer for all shares in Swedish Match.
  • Represented Neurim Pharmaceuticals in patent litigation against a producer of generics.

DLA Piper Sweden

DLA Piper Sweden leverages its international network to advise its broad client base on pricing and reimbursement issues. Practice head Fredrika Allard is noted for her specialism in regulation governing the marketing of pharmaceuticals and collaborations between health professionals within the pharma industry, while competition specialist Erik Brändt Öfverholm has deep knowledge of domestic merger control mandates. Jennie Nilsson leads the firm’s digital, data and cyber group, regularly handling GDPR management projects and issues concerning transparency obligations and intra-group data transfers between companies.

Responsables de la pratique:

Fredrika Allard


Autres avocats clés:

Erik Brändt Öfverholm; Jennie Nilsson


Les références

‘The local representatives in Sweden were very pleasant, competent, efficient and delivered all tasks in a timely manner and according to all specs.’

‘I, as team leader from the Nordics, must mention that Fredrika Allard is extremely professional and knowledgeable in the field of pharma. She was always available to discuss, always took the time to re-evaluate if needed and adjusted the work and final product to our specific needs. I couldn’t give enough high praise for a job well done so far.’

‘Knowledgeable and accessible.’

Principaux clients

Jazz Pharmaceuticals


Gilead Sciences Sweden AB


Pfizer


Ipsen Pharmaceuticals


ITB-Med AB


Qbtech AB


Dynamic Code AB


Doctrin AB


HerCare Sweden AB


Attendo


Läkemedelsindustriföreningen (Lif)


Dexcom


Kartos Therapeutics LLC


Syneos Health


ABC Labs


Karolinska Development


Imagine Care


10xGenomics


RFSU


e-Verifikation i Sverige AB


Principaux dossiers


  • Advised a US-based biotech company on questions regarding the transfer of human biological samples under new biobank legislation.
  • Advised ITB-Med, a Swedish biopharmaceutical company developing specific immunomodulatory biologics for transplantation, autoimmunity, neurodegenerative diseases and gene therapy, on various data protection matters, including issues relating to clinical trials.
  • Advised a pharmaceuticals company on reimbursement and administrative procedural law issues in relation to a decision issued by the Swedish Dental and Pharmaceutical Benefits Agency.

TM & Partners

The ‘fantastic‘ team at TM & Partners handles the full gamut of work relating to employment, commercial transactions, and compliance issues. Practice co-head Fredrik Gustafsson is an IT specialist who advises on IT procurements and strategic outsourcing mandates, while co-head Anna Jerndorf is known for her employment expertise. Equity capital markets expert Johan Wigh handles a wide variety of transactional matters, including the offering of preference shares and M&A transactions.

Responsables de la pratique:

Fredrik Gustafsson; Anna Jerndorf; Johan Wigh


Les références

‘TM has extensive and deep knowledge within our sector, which gives us excellent support.’

‘Johan Wigh delivers high-quality service in a very personal and professional way.’

‘Fantastic team.’

Principaux clients

Air Liquide Biogas Solution Europe


Apoteket


Coala-Life Group AB


Otsuka Pharma


Veranex


Swemac


Team Olivia Group


Vivesto AB


Principaux dossiers


  • Advising Otsuka Pharma on various legal matters.
  • Acting as Swedish counsel to Veranex in connection with all Swedish law aspects of its acquisition of Devicia and Clarvin together with affiliated companies Kickfile, Lea Group and Limulus Bio.